COŞKUN BENLİDAYI, İ. 2022. How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.25, no.8 , 945-949.

COŞKUN BENLİDAYI, İ., (2022). How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.25, no.8, 945-949.

COŞKUN BENLİDAYI, İLKE. "How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary," INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.25, no.8, 945-949, 2022

COŞKUN BENLİDAYI, İLKE C. . "How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.25, no.8, pp.945-949, 2022

COŞKUN BENLİDAYI, İ. (2022) . "How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.25, no.8, pp.945-949.

@article{article, author={İLKE COŞKUN BENLİDAYI}, title={How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary}, journal={INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES}, year=2022, pages={945-949} }